Using our ‘tau biosensor larvae’, which express full-length human tau and Tau4R-GFP (Alyenbaawi et al., 2021), we measured tau pathology after varying TBI intensities to optimize detectable tauopathy. This evidence concerns the gene MAPT and tauopathy.